New research suggests that patients who come off new GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who end conventional lifestyle plans.
Findings released in a major health publication demonstrates that while obese people often shed a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing these medications must be informed of the potential of quick weight regain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting mass within about a year and a half.
Weighing Treatments
The research, which reviewed 37 of trials involving over 9,000 of participants, contrasted the results of the injectable medications with other pills.
Researchers note that individuals who lose weight through lifestyle changes alone usually experience a more gradual weight regain—approximately 0.1 kg a month—post-intervention.
Explaining the Quick Rebound
Nutrition scientists suggest the mechanism of the injections is key to understanding the accelerated rebound.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Artificially providing the hormone levels far above than normal might result in the system to produce less of its endogenous hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication means appetite is unsuppressed, making excessive eating far more likely."
A Chronic Issue?
Medical guidelines advise the injections for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
A number of clinicians argue that, given the significant potential of weight regain, the therapy should be considered life-long.
This view is echoed by pharmaceutical companies, who say that the results "underscore the persistent nature of excess weight," akin to managing diseases like diabetes.
User Testimonies
Users who have discontinued the jabs describe a powerful return of hunger.
"It was like a switch flipping and you're instantly starving," said one woman.
The struggle is worsened if patients have not developed lasting lifestyle or habit changes during treatment.
Widespread Use
Figures show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is more common among women than men.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
Finally, experts emphasize that while these medications are potent agents for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on combined behavioural changes.